TardiMed Sciences LLC

10% OwnerTimber Pharmaceuticals, Inc. (TMBR) · full profile →Form 4 · filed Jun 10, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$750K
Net Open-Market Flow
-$750K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2021Sell(S)185K$1.26$233K4.8M
Jun 9, 2021Sell(S)96K$1.27$123K5.0M
Jun 8, 2021Sell(S)306K$1.29$394K5.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-079574) within minutes of acceptance. Every field above traces to the original document. Verify it directly: